- Home
- APGE vs WD Comparison
APGE vs WD Comparison
Compare APGE & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- WD
- Stock Information
- Founded
- APGE 2022
- WD 1937
- Country
- APGE United States
- WD United States
- Employees
- APGE N/A
- WD N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- WD Finance: Consumer Services
- Sector
- APGE Health Care
- WD Finance
- Exchange
- APGE Nasdaq
- WD Nasdaq
- Market Cap
- APGE 2.0B
- WD 2.4B
- IPO Year
- APGE 2023
- WD 2010
- Fundamental
- Price
- APGE $37.63
- WD $85.37
- Analyst Decision
- APGE Strong Buy
- WD Buy
- Analyst Count
- APGE 5
- WD 2
- Target Price
- APGE $95.40
- WD $102.50
- AVG Volume (30 Days)
- APGE 465.5K
- WD 211.2K
- Earning Date
- APGE 11-11-2025
- WD 11-06-2025
- Dividend Yield
- APGE N/A
- WD 3.16%
- EPS Growth
- APGE N/A
- WD 25.06
- EPS
- APGE N/A
- WD 3.24
- Revenue
- APGE N/A
- WD $1,111,017,000.00
- Revenue This Year
- APGE N/A
- WD $18.16
- Revenue Next Year
- APGE N/A
- WD $5.63
- P/E Ratio
- APGE N/A
- WD $26.23
- Revenue Growth
- APGE N/A
- WD 15.06
- 52 Week Low
- APGE $26.20
- WD $64.48
- 52 Week High
- APGE $63.50
- WD $118.19
- Technical
- Relative Strength Index (RSI)
- APGE 50.77
- WD 54.60
- Support Level
- APGE $36.01
- WD $84.49
- Resistance Level
- APGE $37.97
- WD $88.06
- Average True Range (ATR)
- APGE 1.66
- WD 2.02
- MACD
- APGE 0.02
- WD -0.38
- Stochastic Oscillator
- APGE 56.28
- WD 57.70
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About WD Walker & Dunlop Inc
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.